District health plan set to exclude GLP‑1 drugs for obesity; 2.5% premium renewal approved

The Brainerd Public School District insurance committee recommended and the board approved a health‑insurance renewal that trims the district’s expected premium increase to 2.5% by both adjusting the drug formulary and drawing on the insurance fund balance.

Aaron and committee members said an initial renewal came in at 7.5%, driven in part by rising claims related to GLP‑1 medications prescribed for obesity. "We spent about $500,000 on that last year," said a committee representative, noting the middle‑double‑digit growth trend for that class of medications. The recommendation narrows coverage by excluding GLP‑1 drugs when the primary diagnosis is obesity while preserving coverage for those drugs when prescribed for type 2 diabetes, sleep apnea, cardiovascular conditions or other approved diagnoses.

The committee proposed using available fund balance to lower the immediate premium increase and asked the board to make the formulary change effective Sept. 1 to coincide with open enrollment. The change is contingent on getting memoranda of understanding in place with all unionized employee groups because the district’s insurance plan is underwritten for employee groups jointly; if agreements are not reached by July 1, the committee said it would recommend a 5% premium increase instead.

The board discussed employee communication and transition planning; staff noted employees will have time to plan with their physicians and that exceptions exist for medically appropriate uses unrelated to primary obesity. The motion to approve the 2.5% renewal and associated recommendation passed on the consent of the board.